AdAlta Ltd

NEW
FRA:JDA (Australia)  
€ 0.0015 (0%) Jul 2
At Loss
Market Cap:
€ 5.56M ($ 6.36M)
Enterprise V:
€ 5.84M ($ 6.68M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Description
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation cells and protein based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
0.9
Equity-to-Asset
-0.12
Debt-to-Equity
-8.07
Debt-to-EBITDA
-0.44
Piotroski F-Score
1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
27
3-Year EPS without NRI Growth Rate
27
3-Year FCF Growth Rate
30.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
85.81
9-Day RSI
64.93
14-Day RSI
56.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.89
Quick Ratio
0.89
Cash Ratio
0.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-42
Shareholder Yield %
-16.27

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-628.77
ROA %
-206.78
ROIC %
-1330.83
3-Year ROIIC %
-126.07
ROC (Joel Greenblatt) %
-1653.04
ROCE %
-549.04

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-3.03
EV-to-EBITDA
-3.04
EV-to-FCF
-5.06
Earnings Yield (Greenblatt) %
-33
FCF Yield %
-20.53

Financials

FRA:JDA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

AdAlta Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.003
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 56.05
14-Day ATR (€) 0.000143
20-Day SMA (€) 0.00115
12-1 Month Momentum % -
52-Week Range (€) 0.0007 - 0.004
Shares Outstanding (Mil) 3,212.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AdAlta Ltd Filings

Filing Date Document Date Form
No Filing Data

AdAlta Ltd Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

AdAlta Ltd Frequently Asked Questions

What is AdAlta Ltd(FRA:JDA)'s stock price today?
The current price of FRA:JDA is €0.00. The 52 week high of FRA:JDA is €0.00 and 52 week low is €0.00.
When is next earnings date of AdAlta Ltd(FRA:JDA)?
The next earnings date of AdAlta Ltd(FRA:JDA) is .
Does AdAlta Ltd(FRA:JDA) pay dividends? If so, how much?
AdAlta Ltd(FRA:JDA) does not pay dividend.

Articles on AdAlta Ltd

No articles.